Our Company
Become a part of the Celsus Team Join our team. Let's make the world a better place with CelsusCelsius services have processed more than 2 million studies
Key persons
Become a part of Celsus Team!
Join our team, make the world a better place with Celsus!
- Founding of the company and the beginning of research work
- Commencement of development of a solution for diagnosing breast cancer based on artificial intelligence technologies
- Release of the first version of the Celsus.Mammography system
- Signing of the Memorandum of Cooperation in the development and application of artificial intelligence by medical organizations (21 subjects joined)
- Start of pilot operation in the regions
- Release of the first version of the system Celsus.Fluorography
- Inclusion in Subcommittee 01 of the Technical Committee (TC 164) on the development of GOST for artificial intelligence systems in clinical medicine. Joining the National Medical Knowledge Base (NMKB)
- Celsus solutions for mammography and fluorography passed calibration testing to participate in an experiment on the use of services based on AI technologies in the Moscow healthcare system
- Summing up the results of pilot projects in the Republic of Dagestan, Bryansk and Tambov regions
- Conducting the first in Russia selection of doctors for marking data involved in training artificial intelligence - #ChallengeRadiologist
- Attraction of the first round of investments from the NTI venture fund
- Already 3 Celsus services are used by medical institutions as part of the Moscow experiment: mammography, fluorography, and CT (COVID-19)
- Victory in the finals of the iLAB Innovation Lab, an accelerator program of the Skolkovo Foundation and AstraZeneca
- Celsus for the analysis of mammography and fluorography became the first AI system in Russia to receive the status of a medical device according to 3, the highest hazard class. Passing the test for compliance with EU directives and obtaining the CE mark
- Inclusion in the Go Global initiative of the Agency for Strategic Initiatives
- Signing an agreement with the Ministry of Health of Uzbekistan on cooperation
- Receiving the Technological Breakthrough Award and winning the Digital Healthcare Lab
- Release of a system for the analysis of brain CT
- Co-authorship on an article on the use of artificial intelligence in MRI diagnostics of rectal cancer
- Launch of an online course from Sechenov University with the participation of Celsus “Digital Technologies in Medicine”
Celsus Aulus Cornelius was a Roman scientist, encyclopedist
and doctor. He was one of the first who began to systematize
disordered medical knowledge and definitions. He made an outstanding
contribution to the development of pathology,
traumatology and surgery. Many of
the operations described by Celsus have not changed to this day!
The essay "On Medicine" is his largest work, which has become
one of the pillars of fundamental medical science.
Aulus Cornelius Celsus owns the authorship of the quote:
"You can't cure what you couldn't recognize." It inspired us to name the company and
technology in honor of this great scientist and doctor.
We are proud of the solutions that we create and implement
in clinical practice – and we want to help doctors to help their patients. We work to
perform their job on the recognition and treatment of diseases even more effectively
Awards
Roscongress Business Priority contest “Top 10 Innovative Companies in Healthcare” winner
Grand prix in the battle ‘Radiologists vs. AI’
Educational intensive course “Winter Island” participant, “Top 15 Best Investment Projects” winner
“Digital Summit” award in the nomination “Best Artificial Intelligence Solution for Higher Efficiency”
Patents and certificates
Registered Trademarks Celsus ® / Celsus ® and the right to a computer program
Patent for the invention Celsus ® (Celsus ® Technologies), which confirms the uniqueness of the solution.
Celsus® submitted to the Unified Register of Russian Computer Software and Databases by Order of Ministry of Communications of the Russian Federation No. 429 dated 31.08.2020.
Registration certificate of a medical device No. RZN 2021/14449.
CE mark (SK-CA-001/DVC-SK-21-06-000018).